Cox univariate analysis with binarized Bcl-2 scores revealed that high Bcl-2 expression resulted in 41% reduction in risk for all NSCLC patients (hazards ratio-HR = 0.59, 95% confidence interval-CI 0.4-0.87, p = 0.009). Here, BCL2 is linked to non-small cell lung carcinoma.